This content is not available in your region

Baby steps to emerging market growth

Access to the comments Comments
By Euronews
Baby steps to emerging market growth

<p>$11.8 billion is the price Nestle is going to pay for US firm Pfizer’s infant nutrition business . That is about two billion more than the maximum expected by investors. </p> <p>In Behind Markets we look at the reasons for the high price and the effects it had. </p> <p>Click on the link above to see the report</p>